Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Andrew Pollard, named as one of three 2019 Rosén von Rosenstein laureates.

The Rosén von Rosenstein Medal is awarded by the University of Uppsala, Sweden

Andy Pollard receives the Rosen von Rosenstein MedalThe Rosén von Rosenstein Medal, awarded by the Swedish Paediatric Society and the Swedish Society of Medicine every five years since 1964, is recognised as the most prestigious prize within paediatrics.

Andrew Pollard is Professor of Paediatric Infection and Immunity at the University of Oxford, Director of the Oxford Vaccine Group, Honorary Consultant Paediatrician at Oxford Children’s Hospital and Vice Master of St Cross College. His research includes the design, development and clinical evaluation of vaccines including those for meningococcal disease and enteric fever and leads studies using a human challenge model of (para)typhoid. He runs surveillance for invasive bacterial diseases and studies the impact of pneumococcal vaccines in children in Nepal; he also leads a project on burden and transmission of typhoid in Nepal, Bangladesh and Malawi, and co-leads typhoid vaccine impact studies at these sites. He has supervised 37 PhD students and his publications includes over 500 manuscripts and books on various topics in paediatrics and infectious diseases. He chairs the UK Department of Health and Social Care’s Joint Committee on Vaccination and Immunisation and the European Medicines Agency scientific advisory group on vaccines and is a member of WHO’s SAGE. He was elected to the Academy of Medical Sciences in 2016 and is an NIHR Senior Investigator. His recent recognitions include the Bill Marshall award of the European Society for Paediatric Infectious Disease (ESPID) in 2013 for his contribution to the specialty, and the ESPID Distinguished Award for Education & Communication in 2015.

Professor Pollard received the medal in a ceremony on 27 September and delivered a lecture in the Children's Hospital at Uppsala.

About the award

The prize commemorates Nils Rosén von Rosenstein (1706-1773), a Swedish physician and the founder of modern paediatrics. Following studies at the universities of Lund and Uppsala, Rosén von Rosenstein travelled to several European countries and obtained a medical degree in Haarderwijk in 1730. He subsequently returned to take up a lectureship in Uppsala, where he was Carl Linnaeus’ contemporary. In 1743 he was appointed royal physician. In 1764, Rosén von Rosenstein published “The diseases of children, and their remedies”, considered to be the first modern textbook on the subject.

Similar stories

Vaccine for TB receives a $1.5 million funding boost

The Oxford-run VALIDATE Network has received $1.5 million in funding for its tuberculosis vaccine work from the Bill & Melinda Gates Foundation.

University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

Oxford Vaccine Group among winners at NHS Parliamentary awards

Researchers behind the Oxford AstraZeneca coronavirus vaccine have been recognised for their excellence at a healthcare awards ceremony.

New book highlights life-saving role vaccines play in prevention of killer diseases

'Brain Fever', a new book by internationally-renowned medical scientist Professor Richard Moxon, describes the decades of research that contribute to the development of vaccines for life-threatening illnesses such as meningitis, and how immunisation has been our greatest public health intervention.